Gallivac IB88: Further information
|
Gallivac IB88
Further information
The vaccine contains the live attenuated CR88121 strain of Infectious Bronchitis, belonging to the CR88 (793B) group of the variant coronaviruses. After administration, the vaccine induces an active immunisation against the variant coronaviruses of group CR88 (793B). The duration of immunity is at least five weeks.
|
 |
 
        |
 |
|
|
|
|||||||||||||||||||||||||
Date updated: 18 May 2005